Stock Events

Stock Events

Fortress Biotech 

$16.67
356
-$0.10-0.6%Thursday 20:00
+$0.00+0%Thursday 20:00After hours

Statistics

Day High
16.98
Day Low
16.3
52W High
21.43
52W Low
6.27
Volume
6,762
Avg. Volume
11,743
Mkt Cap
555.96M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jun 2024
$0.20
May 2024
$0.20
Apr 2024
$0.20
Mar 2024
$0.20
Feb 2024
$0.20
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Nov 16Expected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.76
0.43
1.63
2.82
Expected EPS
-0.27
Actual EPS
N/A

Financials

-2.97%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
63.26MRevenue
-1.88MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FBIOP. It's not an investment recommendation.
AGNC Investment
61
AGNC
Realty Income
59
O
Arbor Realty Trust
59
ABR
Ares Capital
46
ARCC

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Agenus
AGEN
Mkt Cap377.55M
Agenus Inc. focuses on immuno-oncology, a field that overlaps with some of Fortress Biotech's projects in cancer treatment, making them direct competitors.
Alnylam Pharmaceuticals
ALNY
Mkt Cap29.4B
Alnylam Pharmaceuticals is pioneering in RNAi therapeutics, a novel form of treatment that could compete with FBIO's diverse biotech portfolio.
AMGEN
AMGN
Mkt Cap217.9B
Amgen is a larger biotechnology firm with a broad focus, including treatments for illnesses that FBIO also targets, making them a competitor by virtue of overlapping therapeutic areas.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.07B
BioMarin Pharmaceutical focuses on enzyme replacement therapies, directly competing with FBIO's interest in rare diseases.
CRISPR Therapeutics
CRSP
Mkt Cap5.36B
CRISPR Therapeutics is at the forefront of gene editing, a revolutionary approach that could compete with FBIO's gene therapy projects.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences has a broad portfolio including oncology, infectious diseases, and inflammatory disorders, overlapping with FBIO's areas of interest.
Incyte
INCY
Mkt Cap23.37B
Incyte Corporation focuses on oncology and inflammation, directly competing with FBIO in the development of treatments for cancer and rare diseases.
Vertex Pharmaceuticals
VRTX
Mkt Cap127.93B
Vertex Pharmaceuticals is known for its work in treating cystic fibrosis, a rare disease area that FBIO is also interested in, making them competitors.

About

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Show More
CEO
Lindsay A. Rosenwald
Employees
78
Country
United States
ISIN
US34960Q2084

Listings

MU
DE
CNB.MU
STU
DE
CNB.STU
F
DE
CNB0.F
XNAS
US
FBIO

0 Comments

Share your thoughts

FAQs

What is Fortress Biotech stock price today?▼
The current price of FBIOP is $16.67 USD — it has decreased by -0.6% in the past 24 hours. Watch Fortress Biotech stock price performance more closely on the chart.
What is Fortress Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Fortress Biotech stocks are traded under the ticker FBIOP.
Is Fortress Biotech stock price growing?▼
FBIOP stock has risen by +0% compared to the previous week, the month change is a -2.23% fall, over the last year Fortress Biotech has showed a +146.96% increase.
What is Fortress Biotech market cap?▼
Today Fortress Biotech has the market capitalization of 555.96M
When is the next Fortress Biotech earnings date?▼
Fortress Biotech is going to release the next earnings report on November 16, 2026.
What were Fortress Biotech earnings last quarter?▼
FBIOP earnings for the last quarter are -0.08 USD per share, whereas the estimation was -0.2 USD resulting in a +60% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Fortress Biotech revenue for the last year?▼
Fortress Biotech revenue for the last year amounts to 63.26M USD.
What is Fortress Biotech net income for the last year?▼
FBIOP net income for the last year is -1.88M USD.
Does Fortress Biotech pay dividends?▼
Yes, FBIOP dividends are paid monthly. The last dividend per share was 0.2 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Fortress Biotech have?▼
As of October 23, 2026, the company has 78 employees.
In which sector is Fortress Biotech located?▼
Fortress Biotech operates in the Health & Wellness sector.
When did Fortress Biotech complete a stock split?▼
The last stock split for Fortress Biotech was on October 10, 2023 with a ratio of 1:15.
Where is Fortress Biotech headquartered?▼
Fortress Biotech is headquartered in BAY HARBOR ISLANDS, United States.